• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名携带LRRK2 I1371V变异的东印度裔帕金森病患者中生成诱导多能干细胞(NIMHi001-A)。

Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.

作者信息

Datta Indrani, Jagtap Soham, Potdar Chandrakanta, Yadav Ravi, Pal Pramod

机构信息

Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru 560029, Karnataka, India.

Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru 560029, Karnataka, India.

出版信息

Stem Cell Res. 2020 Apr;44:101768. doi: 10.1016/j.scr.2020.101768. Epub 2020 Mar 17.

DOI:10.1016/j.scr.2020.101768
PMID:32244201
Abstract

Mutations in the Leucine Repeat Rich Kinase-2 (LRRK2) gene have been reported in familial Parkinson's disease (PD) cases. We have generated induced pluripotent stem cells (iPSCs) using Sendai-virus reprogramming-method from peripheral blood mononuclear cells of PD-patient of East-Indian ethnicity carrying the I1371V mutation in LRRK2 gene. PD diagnosis was performed using Unified Parkinson's Disease rating scale (UPDRS) score and confirmed by [F]fluoro-l-dopa [F-DOPA] positron emission tomography (F-DOPA PET). The iPSC line was characterized for self-renewal and pluripotency. This cellular model will provide a valuable resource not only for drug-screening platform but also to understand the pathophysiology of this disease.

摘要

在家族性帕金森病(PD)病例中,已报道亮氨酸重复激酶2(LRRK2)基因发生突变。我们使用仙台病毒重编程方法,从携带LRRK2基因I1371V突变的东印度裔PD患者的外周血单个核细胞中生成了诱导多能干细胞(iPSC)。使用统一帕金森病评定量表(UPDRS)评分进行PD诊断,并通过[F]氟代左旋多巴[F-DOPA]正电子发射断层扫描(F-DOPA PET)进行确认。对该iPSC系进行了自我更新和多能性特征分析。这个细胞模型不仅将为药物筛选平台提供宝贵资源,还将有助于理解这种疾病的病理生理学。

相似文献

1
Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.从一名携带LRRK2 I1371V变异的东印度裔帕金森病患者中生成诱导多能干细胞(NIMHi001-A)。
Stem Cell Res. 2020 Apr;44:101768. doi: 10.1016/j.scr.2020.101768. Epub 2020 Mar 17.
2
Generation of induced pluripotent stem cells (NIMHi002-A and NIMHi003-A) from two sporadic Parkinson's disease patient of East Indian ethnicity.从两名东印度族散发性帕金森病患者中诱导生成多能干细胞(NIMHi002 - A和NIMHi003 - A)。
Stem Cell Res. 2020 Dec;49:101995. doi: 10.1016/j.scr.2020.101995. Epub 2020 Sep 17.
3
Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.从携带LRRK2 p.I1371V突变的帕金森病患者中生成诱导多能干细胞(IBMSi011-A)。
Stem Cell Res. 2019 May;37:101447. doi: 10.1016/j.scr.2019.101447. Epub 2019 Apr 22.
4
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.源自携带LRRK2 G2385R变异的帕金森病患者的2个诱导多能干细胞系的产生。
Stem Cell Res. 2018 Apr;28:1-5. doi: 10.1016/j.scr.2018.01.034. Epub 2018 Feb 28.
5
Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.从携带LRRK2 p.I2012T突变的帕金森病患者中诱导产生多能干细胞。
Stem Cell Res. 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020. Epub 2017 Oct 31.
6
Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2.从携带 LRRK2 基因 I2020T 突变的家族性帕金森病 PARK8 患者诱导多能干细胞中生成基因校正的诱导多能干细胞系(KEIUi001-A)。
Stem Cell Res. 2020 Dec;49:102073. doi: 10.1016/j.scr.2020.102073. Epub 2020 Nov 3.
7
Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation.从一名携带LRRK2 p.G2019S突变的帕金森病患者中生成诱导多能干细胞系(DANi-011A)。
Stem Cell Res. 2020 May;45:101781. doi: 10.1016/j.scr.2020.101781. Epub 2020 Mar 29.
8
Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.从一名在亮氨酸丰富重复激酶 2(LRRK2)基因中携带 p.G2019S 突变的帕金森病患者身上生成诱导多能干细胞系(CSC-41)。
Stem Cell Res. 2018 Apr;28:44-47. doi: 10.1016/j.scr.2018.01.022. Epub 2018 Feb 2.
9
Impaired Sonic Hedgehog Responsiveness of Induced Pluripotent Stem Cell-Derived Floor Plate Cells Carrying the LRRK2-I1371V Mutation Contributes to the Ontogenic Origin of Lower Dopaminergic Neuron Yield.携带 LRRK2-I1371V 突变的诱导多能干细胞衍生的基板细胞 Sonic Hedgehog 反应受损导致中脑多巴胺神经元产量减少。
Stem Cells Dev. 2024 Jun;33(11-12):306-320. doi: 10.1089/scd.2023.0283. Epub 2024 Jun 3.
10
Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.从携带双基因突变 LRRK2 p.G2019S 和 GBA1 p.N409S 的帕金森病患者中诱导多能干细胞的产生和特性鉴定。
Stem Cell Res. 2023 Oct;72:103212. doi: 10.1016/j.scr.2023.103212. Epub 2023 Sep 28.

引用本文的文献

1
Genetic Sketch of Parkinson's Disease in India.印度帕金森病的基因概述。
Ann Indian Acad Neurol. 2025 Jul 1;28(4):495-504. doi: 10.4103/aian.aian_1021_24. Epub 2025 May 7.
2
Astrocytes Differentiated from LRRK2-I1371V Parkinson's-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery.LRRK2-I1371V 帕金森病诱导多能干细胞分化的星形胶质细胞在谷氨酸摄取和代谢、ATP 生成以及 Nrf2 介导的谷胱甘肽机制方面表现出相似的产量,但存在细胞内功能障碍。
Cells. 2023 Jun 8;12(12):1592. doi: 10.3390/cells12121592.
3
Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro.
诱导多能干细胞衍生的人类肺类器官用于体外绘制和治疗 SARS-CoV2 感染。
Adv Exp Med Biol. 2021;1312:1-17. doi: 10.1007/5584_2020_613.
4
Recovery of Human Embryonic Stem Cells-Derived Neural Progenitors Exposed to Hypoxic-Ischemic-Reperfusion Injury by Indirect Exposure to Wharton's Jelly Mesenchymal Stem Cells Through Phosphatidyl-inositol-3-Kinase Pathway.缺氧缺血再灌注损伤后,通过磷酸肌醇-3-激酶通路间接暴露于人脐带 Wharton jelly 间充质干细胞对人胚胎干细胞源性神经祖细胞的恢复作用。
Cell Mol Neurobiol. 2022 May;42(4):1167-1188. doi: 10.1007/s10571-020-01007-w. Epub 2020 Nov 18.